Immune health supplements are essential for managing chronic illnesses like diabetes, obesity, constipation, malabsorption, and indigestion. It also aids in the maintenance of a healthy lifestyle, the improvement of appetite and food intake, and the reduction of the danger of vitamin deficiencies and other health problems. Immune health supplements are indicated for patients of all ages, including newborns, adults, and geriatrics, who are at risk for diabetes, obesity, renal failure, chronic diseases, neurological diseases, and other illnesses. As a result of these reasons, demand for immune health supplements has increased.
In 2020, the global immune health supplement market is predicted to be worth US$ 15,441.9 million, growing at a CAGR of 7.1 percent over the forecast period (2020-2027).
Over the forecast period, the launch of various immune health supplement products is expected to fuel the worldwide immune health supplement market growth. Conagen Inc., a biotechnology business, said in March 2020 that it has discovered a sustainable unique lactoferrin protein that mimics the nutritional qualities of lactoferrin found in breast milk.
Due to the rising prevalence of chronic diseases and other ailments among the senior population, the immune health supplements market is likely to develop significantly over the forecast period. According to a report released by the World Health Organization in September 2019, about 50 million people worldwide suffer from dementia, with nearly 10 million new cases diagnosed each year. According to the same source, Alzheimer's disease is the most common kind of dementia, accounting for 60–70% of all cases.
The COVID-19 virus has spread to over 100 nations since its outbreak in December 2019, prompting the World Health Organization to designate it a public health emergency in March 2020. According to a World Health Organization estimate, coronavirus (COVID-19) has infected over 153 million people worldwide as of May 4, 2021.
The COVID-19 pandemic has had three main effects on the economy: directly influencing output and demand, causing distribution channel disruptions, and having a financial impact on enterprises and financial markets. Several countries, including China, India, Saudi Arabia, the United Arab Emirates, Egypt, and others, are experiencing difficulties transporting goods from one location to another as a result of nationwide lockdowns.
Furthermore, the COVID-19 pandemic is posing significant challenges to participants in the global immune health supplement market on multiple fronts. The supply of raw materials required for producing immune health supplements is a serious difficulty due to transportation anomalies. Furthermore, due to a surge in the number of patients suffering from COVID-19 and other life-threatening conditions, distributors are seeing erratic demand for items from retailers.
Side effects and the high cost of immune health supplement products, as well as a lack of information about nutritional diet in low- and middle-income nations, are the key factors limiting the worldwide immune health supplement market's growth. In rural areas of low- and middle-income economies in Africa and the Asia Pacific region, there is a lack of understanding about nutritional goods and diseases related with nutritional inadequacies. This is projected to impede the adoption of medical nutritional products in these areas, hampereding industry expansion.
Abbott Nutrition, Bayer AG, Glanbia, Plc., EuroPharma, Inc., Bio Tech Pharmacal, Vital Nutrients, Herbalife Nutrition Ltd, Vitabiotics Ltd., NutriGold Inc., BioGaia, Natural Immunogenics, and Nutramax Laboratories are some of the major competitors in the worldwide immune health supplement industry.
Comments
Post a Comment